# Novel Regimens in COVID-19 Treatment

> **NCT04382846** · PHASE3 · RECRUITING · sponsor: **Tanta University** · enrollment: 160 (estimated)

## Conditions studied

- COVID
- Corona Virus Infection

## Interventions

- **DRUG:** Nitazoxanide

## Key facts

- **NCT ID:** NCT04382846
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-05-08
- **Primary completion:** 2030-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2020-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04382846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04382846, "Novel Regimens in COVID-19 Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04382846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*